An Estimate of Average Cost of Hypertension and its catastrophic effect on the people living with hypertension: Patients’ perception from two Hospitals in Abuja, Nigeria

Idris  Abubakar; Obansa S. A. J

doi:10.36923/ijsser.v2i2.62

Open Access Article Psychology and Behavioral Economics

Idris Abubakar ⁽¹⁾, Obansa S. A. J ⁽²⁾

(1) Department of Economics, Faculty of Social Science University of Abuja, Nigeria,

(2) Department of Economics, Faculty of Social Science University of Abuja, Nigeria

https://doi.org/10.36923/ijsser.v2i2.62

Issue
Vol. 2 No. 2 (2020)

Submitted
March 27, 2020

Published
June 27, 2020

Keywords:

Hypertension, Catastrophic spending, Personal spending, Least income, Urban dwellers, Intervention scheme

Download PDF

Abstract

The study aimed to investigate the high prevalence and associated costs of treating hypertension, focusing on its direct average cost and its catastrophic effect on sufferers in Nigeria. Utilizing a descriptive survey research design, data were collected through structured questionnaires administered to patients at the University of Abuja Teaching Hospital and National Hospital, Abuja, Nigeria. The data were analyzed using SPSS version 22, with frequency and percentage calculations. Findings revealed that the average annual cost of treating hypertension was N145,086.12 per patient. Additionally, 191 (82%) patients undertook personal health spending, with 30.5% of the lowest-income patients experiencing catastrophic health expenditures. The results indicated that the cost of treating hypertension was significantly high among urban dwellers and catastrophic for the least earners. The study concluded that the average cost of treating hypertension in urban areas of Nigeria is substantial and particularly burdensome for low-income patients. The findings highlight the need for targeted healthcare financing policies and intervention schemes to alleviate the economic burden of hypertension on sufferers. The study's results are pertinent for policymakers, health planners, and administrators. They underscore the necessity for government intervention through healthcare financing policies and the establishment of programs to subsidize the costs of hypertension treatment. Additionally, the study provides valuable insights for researchers and academics, contributing to the existing knowledge on the economic burden of hypertension and informing future healthcare intervention strategies.

Full text article

Generated from XML file

References

Abegunde, O. D., & Stanciole, A. (2006). An estimation of the economic impact of chronic non-communicable diseases in selected countries. Working paper, World Health Organisation. Retrieved from http://www.who.int/chp

Adane, E., Atanafu, A., & Aschalew, A. Y. (2020). The cost of hypertension and associated factors, University of Gondar Comprehensive Specialised Hospital Northwest, Ethiopia, 2018. ClinicoEconomics and Outcomes Research Journal, 12, 133-140. https://doi.org/10.2147/CEOR.S234674

Bakare, O. Q., Akinyinka, M. R., Goodman, O., Kuyinu, Y. A., Wright, O. K., Adeniran, A., ... & Osibogun, A. (2016). Antihypertensive use, prescription patterns, and cost of medications in a teaching hospital in Lagos, Nigeria. Nigerian Journal of Clinical Practice, 19(5), 668-672. https://doi.org/10.4103/1119-3077.188709

Bloom, D. E., Cafiero, E. T., McGovern, M. E., Prettner, K., Stanciole, A., Weiss, J., ... & Rosenberg, L. (2013). The economic impact of non-communicable disease in China and India: estimates, projections, and comparisons (No. w19335). National Bureau of Economic Research. https://doi.org/10.3386/w19335

Chao, S. (2013). Economic impact of non-communicable diseases in the Caribbean. The World Bank Caribbean Health Financing Conference, November 12-14, 2013.

Dzau, V. J., & Balatbat, C. A. (2019). Future of hypertension: The need for transformation. Hypertension, 74(3), 450-457. https://doi.org/10.1161/HYPERTENSIONAHA.119.13437

Ekman, B. (2007). Catastrophic health payments and health insurance: Some counterintuitive evidence from one low-income country. Health Policy, 83(2-3), 304-313. https://doi.org/10.1016/j.healthpol.2007.02.004

Eze, C. O., & Kalu, U. A. (2014). The prognosis of acute stroke in a tertiary health centre in South-East Nigeria. Nigerian Journal of Medicine, 23, 306-310.

Federal Ministry of Health. (1991). National survey on non-communicable diseases in Nigeria.

Gaziano, T. A., Bitton, A., Anand, S., & Weinstein, M. C. (2009). The global cost of nonoptimal blood pressure. Journal of Hypertension, 27(7), 1472-1477. https://doi.org/10.1097/HJH.0b013e32832a9ba3

Ilesanmi, O. S., Ige, O. K., & Adebiyi, A. O. (2012). The managed hypertensive: The costs of blood pressure control in a Nigerian town. Pan African Medical Journal, 12(1), 1-09.

Jha, P., Nugent, R., Varguet, S., Bloom, D., & Hum, R. (2013). Chronic disease assessment: Third Copenhagen consensus. Cambridge University Press. https://doi.org/10.1017/CBO9781139600484.005

Kado, D., Bala, K., & Dandajeh, M. A. (2016). Pareto analysis on the total quality management (TQM) status of the Nigerian design firms. ATBU Journal of Environmental Technology, 9(1), 42-57.

Kengne, A. P., Mchiza, Z. J. R., Amoah, A. G. B., & Mbanya, J. C. (2013). Cardiovascular diseases and diabetes as economic and developmental challenges in Africa. Progress in Cardiovascular Diseases, 56(3), 302-313. https://doi.org/10.1016/j.pcad.2013.10.011

Kirkland, E. B., Heincelman, M., Bishu, K. G., Schumann, S. O., Schreiner, A., Axon, R. N., ... & Moran, W. P. (2018). Trends in healthcare expenditures among US adults with hypertension: National estimates, 2003-2014. Journal of the American Heart Association, 7(11), 1-09. https://doi.org/10.1161/JAHA.118.008731

Krejcie, R. V., & Morgan, D. W. (1970). Determining sample size for research activities. Educational and Psychological Measurement, 30(3), 607-610. https://doi.org/10.1177/001316447003000308

Ndiyo, N. A. (2015). Fundamental of research in behavioural sciences and humanities (14th ed.). Calabar, Nigeria: Excel.

Charles, C. N. C., Azodo, M. N. M., & Chuku, C. A. (2014). Causes and pattern of death in a tertiary hospital in South Eastern Nigeria. Sahel Medical Journal, 17(3), 102-107. https://doi.org/10.4103/1118-8561.140292

Lambo, E. (2007). Socio economic impact of non-communicable diseases.

Li, R., Liang, N., Bu, F., & Hesketh, T. (2020). The effectiveness of self-management of hypertension in adults using mobile health: Systematic review and meta-analysis. JMIR mHealth and uHealth, 8(3), 1-16. https://doi.org/10.2196/17776

Odili, A. N., & Abatta, E. O. (2015). Blood pressure indices, lifestyle factors, and anthropometric correlates of casual blood glucose in a rural Nigerian community. Annals of African Medicine, 1(4), 39-45. https://doi.org/10.4103/1596-3519.148735

Ogah, O., Okpechi, I., Chukwuonye, I. I., Akinyemi, J. O., Onwubere, B. J. C., Falase, A. O., Stewart, S., & Sliwa, K. (2012). Blood pressure, prevalence of hypertension and hypertension-related complications in Nigerian Africans: A review. World Journal of Cardiology, 4(12), 327-340. https://doi.org/10.4330/wjc.v4.i12.327

Okubadejo, N. U., Ozoh, O. B., Ojo, O. O., Akinkugbe, A. O., Odeniyi, I. A., Adegoke, O., ... & Agabi, O. P. (2019). Prevalence of hypertension and blood pressure profile amongst urban-dwelling adults in Nigeria: A comparative analysis based on recent guideline recommendations. Clinical Hypertension, 25(1), 1-09. https://doi.org/10.1186/s40885-019-0112-1

Oyando, R., Njoroge, M., Nguhiu, P., Kirui, F., Mbui, J., Sigilai, A., ... & Barasa, E. (2019). Patient costs of hypertension care in public health care facilities in Kenya. The International Journal of Health Planning and Management, 34(2), e1166-e1178. https://doi.org/10.1002/hpm.2752

Unadike, B. C., Essien, I., Akpan, N. A., Peters, E. J., & Essien, O. E. (2013). Profile outcome of diabetic admissions at the University of Uyo Teaching Hospital, Uyo. International Journal of Medicine and Medical Sciences, 5(6), 286-289. https://doi.org/10.61386/imj.v6i1.102

Wagstaff, A., & Doorslaer, V. (2002). Catastrophic and impoverishment in paying for healthcare: With application to Vietnam 1993-98. Health Economics, 12(11), 921-934. https://doi.org/10.1002/hec.776

Wang, G., Zhou, X., Zhuo, X., & Zhang, P. (2017). Annual total expenditures associated with hypertension by diabetes status in US adults. American Journal of Preventive Medicine, 53(6S2), S182-S189. https://doi.org/10.1016/j.amepre.2017.07.018

Webb, M. C., & Conrad, D. A. (2012). The cost of treating chronic non-communicable diseases: Does it matter? The University of West Indies at St Augustine, 42520, 1-14.

World Health Organization. (2013). A global brief on hypertension: Silent killer, global public health crisis: World Health Day 2013 (No. WHO/DCO/WHD/2013.2). World Health Organization. https://doi.org/10.5005/ijopmr-24-1-2

World Health Organization. (2019). Fact on the prevalence of hypertension. Retrieved from https://www.who.int on April 29, 2020.

Xu, K., Evans, D., Karrin, G., & Aguilar-Rivera, A. M. (2005). Technical brief for policy makers. Designing health financing systems to reduce catastrophic health expenditure. World Health Organization, Department of Health Systems Financing, Health Financing Policy, 1-4.

Yang, Y., Tang, Y., Jiang, H., Chen, Y., Wan, P., Fan, M., ... & Lao, M. (2019). 2020 roadmap on gas-involved photo-and electro-catalysis. Chinese Chemical Letters, 30(12), 2089-2109. https://doi.org/10.1016/j.cclet.2019.10.041

Authors

Idris Abubakar

Department of Economics, Faculty of Social Science University of Abuja

idrisbakr@yahoo.com (Primary Contact)

Obansa S. A. J

Department of Economics, Faculty of Social Science University of Abuja

Abubakar, I., & S. A. J, O. (2020). An Estimate of Average Cost of Hypertension and its catastrophic effect on the people living with hypertension: Patients’ perception from two Hospitals in Abuja, Nigeria. Innovation Journal of Social Sciences and Economic Review, 2(2), 11–20. https://doi.org/10.36923/ijsser.v2i2.62

Download Citation

This work is licensed under a Creative Commons Attribution 4.0 International License.

IJSSER is committed to an open-access model for publishing, ensuring that all of its content is freely available under the terms of the Creative Commons Attribution License (CC BY) 4.0. This policy empowers researchers, academicians, and the general public to freely download, copy, print, and access the links to the full texts of published materials at no cost. Furthermore, authors are encouraged to read, distribute, and submit the published works to their institution's library and any other appropriate repositories.